Boyi Gan

Boyi Gan, Ph.D., is a Professor in the Department of Experimental Radiation Oncology and the Department of Molecular and Cellular Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX. He holds the endowed title of N.G. and Hellen T. Hawkins Distinguished Professor for Cancer Research and serves as Director of both the Acquired Resistance to Therapy and Iron (ARTI) Center and the Radiation and Cancer Metabolism Research Program at MD Anderson.

His research focuses on the molecular and metabolic underpinnings of cancer, particularly in the context of radiation oncology. Key areas include therapy resistance mechanisms, cancer metabolism, and the role of iron in tumor progression and treatment response. His work bridges experimental radiation oncology with molecular oncology to develop novel therapeutic strategies.

Dr. Gan leads major research programs and centers at MD Anderson, indicating a significant leadership role in advancing cancer research. While specific publications and grants are not detailed in the provided text, his directorships and endowed professorship reflect a high-impact research portfolio and national recognition in the field of cancer biology.

• Director, Acquired Resistance to Therapy and Iron (ARTI) Center
• Director, Radiation and Cancer Metabolism Research Program
• Endowed Distinguished Professor for Cancer Research

He has received multiple honors and awards, though specific names are not listed. His work likely involves extensive collaboration, grant funding, and mentorship of trainees, though student names and grant details are not provided.

Dr. Gan is actively contributing to the mission of MD Anderson through innovative research in cancer metabolism and radiation response, positioning him as a key figure in translational and experimental oncology.